The biotech giant is facing over 67,000 US lawsuits over allegations that its Roundup weedkiller causes cancer — a claim Bayer denies. Shares in Bayer rose over 9% during Tuesday morning trading in ...

New study to test Sema3A antibody in rare genetic kidney disease Evotec SE has announced that partner Bayer AG has initiated a phase 2 clinical study of BAY 3401016, a monoclonal antibody targeting ...

Bayer shares rose as much as 15% on Tuesday after the U.S. solicitor general backed the company’s bid to get the Supreme Court to curtail litigation alleging its Roundup pesticide causes cancer.

LEVERKUSEN, Germany--(BUSINESS WIRE)--Bayer is pleased the Solicitor General supports U. S. Supreme Court review of the petition for a writ of certiorari in the Durnell case and agrees with the ...

Bayer is suing insurance giant AIG, alleging decades-old insurance policies should have helped cover billions of dollars in legal costs from Roundup and PCB cases now being shouldered by the German ...

Shares of Bayer BAYN1.37%increase; green up pointing triangle rose as much as 14% on Tuesday after the U.S. Solicitor General supported the company’s push for the Supreme Court to take up its Roundup ...

Wondering if Bayer at €36.50 is a genuine turnaround value play or a classic value trap? This article will walk you through the numbers without the jargon. After years of lacklustre returns, the stock ...

Forbes contributors publish independent expert analyses and insights. I write about men in tights & the billions they make for men in suits. Raw also teased what’s next for Stephanie Vaquer. Judging ...

Investing.com -- Bayer shares jumped on Monday after President Donald Trump’s administration urged the U.S. Supreme Court to take up the company’s bid to limit thousands of lawsuits alleging that ...

Shares of Bayer BAYRY gained 12.1% after the Solicitor General supported a Supreme Court review of its Roundup weedkiller case in the United States. Bayer believes that the backing of the government ...

Trump administration supports Bayer's Supreme Court appeal Bayer faces over 67,000 lawsuits over Roundup's alleged cancer risk Solicitor General says juries should not second-guess EPA's science-based ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. The US government has backed a Supreme Court review of thousands of lawsuits alleging a key ingredient in Bayer ...